pimozide has been researched along with Movement Disorders in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (65.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 1 (5.00) | 29.6817 |
| 2010's | 2 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Julien, JP; Pozzi, S; Thammisetty, SS | 1 |
| Betz, AJ; Clark, K; Felsted, J; Font, L; Hockemeyer, J; Ishiwari, K; Korbey, S; Madson, L; Mirante, B; Muller, CE; Sager, TN; Salamone, JD | 1 |
| Bhutani, T; Busse, KL; Koo, JY; Ladizinski, B | 1 |
| Küstner, R; Siegmund, R | 1 |
| D'Alessandro, R; Guarino, M; Pazzaglia, P; Stracciari, A | 1 |
| Bashir, K; Manyam, BV | 1 |
| Azizi, N; Rezayat, M; Zarrindast, MR | 1 |
| Calne, DB; Claveria, LE; Haskayne, L; Lodge-Patch, IC; Pallis, CA; Petrie, A; Teychenne, PF | 1 |
| Godwin-Austen, RB | 1 |
| Anlezark, GM; Marsden, CD; Meldrum, BS | 1 |
| Avery, GS; Brogden, RN; Pinder, RM; Speight, TM; Spencer, R; Swayer, R | 1 |
| Marsden, CD; Parkes, JD; Tarsy, D | 1 |
| Clark, ML; Costiloe, JP; Hill, D; Huber, WK; Wood, F | 1 |
| Godbout, R; Lorrain, D; Montplaisir, J | 1 |
| Bruun, RD | 1 |
| Lang, AE | 1 |
| Fog, R; Pakkenberg, H | 1 |
| Calne, DB; Claveria, LE; Haskayne, L; Lodge-Patch, IC; Teychenne, PF | 1 |
| Duvoisin, RC; Marsden, CD | 1 |
| Dolphin, A; Duvoisin, RC; Jenner, P; Marsden, CD; Tarsy, D | 1 |
2 review(s) available for pimozide and Movement Disorders
| Article | Year |
|---|---|
Tremorolytic effects of adenosine A2A antagonists: implications for parkinsonism.
Topics: Adenosine A2 Receptor Antagonists; Catalepsy; Humans; Jaw Diseases; Locomotion; Motor Activity; Movement Disorders; Parkinson Disease, Secondary; Pimozide; Purines; Tremor; Xanthines | 2008 |
Pimozide: a review of its pharmacological properties and therapeutic uses in psychiatry.
Topics: Adult; Animals; Anxiety; Behavior, Animal; Child; Dogs; Drug Interactions; Haplorhini; Humans; Lipodystrophy; Mental Disorders; Mice; Movement Disorders; Pimozide; Rabbits; Rats; Schizophrenia; Teratogens | 1976 |
5 trial(s) available for pimozide and Movement Disorders
| Article | Year |
|---|---|
Tardive dyskinesia treated with pimozide.
Topics: Aged; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic; Consciousness Disorders; Drug Therapy, Combination; Female; Fluphenazine; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease, Secondary; Perphenazine; Phenothiazines; Pimozide; Prochlorperazine; Promazine; Promethazine; Schizophrenia; Thioridazine | 1975 |
Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias.
Topics: Aged; Carbidopa; Clinical Trials as Topic; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Metoclopramide; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Parkinson Disease, Secondary; Pimozide; Placebos; Promethazine | 1975 |
Pimozide in chronic schizophrenic outpatients.
Topics: Adult; Ambulatory Care; Basal Ganglia Diseases; Chronic Disease; Consciousness Disorders; Drug Evaluation; Headache; Humans; Male; Middle Aged; Movement Disorders; Outpatient Clinics, Hospital; Pimozide; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Social Adjustment; Thioridazine | 1975 |
Spontaneous oral dyskinesia. Results of treatment with tetrabenazine, pimozide, or both.
Topics: Aged; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Mouth Diseases; Movement Disorders; Parkinson Disease, Secondary; Pimozide; Remission, Spontaneous; Salivary Gland Diseases; Tetrabenazine; Time Factors | 1974 |
Pimozide in tardive dyskinesia.
Topics: Clinical Trials as Topic; Drug Evaluation; Humans; Movement Disorders; Phenothiazines; Pimozide | 1974 |
13 other study(ies) available for pimozide and Movement Disorders
| Article | Year |
|---|---|
Chronic Administration of Pimozide Fails to Attenuate Motor and Pathological Deficits in Two Mouse Models of Amyotrophic Lateral Sclerosis.
Topics: Age Factors; Amyotrophic Lateral Sclerosis; Animals; Anti-Dyskinesia Agents; Body Weight; Botulinum Toxins, Type A; Disease Models, Animal; DNA-Binding Proteins; Female; Humans; Male; Mice; Mice, Transgenic; Motor Activity; Movement Disorders; Muscle Strength; Mutation; Neuromuscular Agents; Neuromuscular Junction; Phosphopyruvate Hydratase; Pimozide; Statistics, Nonparametric; Superoxide Dismutase | 2018 |
Aripiprazole as a viable alternative for treating delusions of parasitosis.
Topics: Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Delusions; Female; Humans; Mental Disorders; Movement Disorders; Parasitic Diseases; Pimozide; Piperazines; Quinolones; Risperidone | 2010 |
Oro-facial dyskinesia treatment with the neuroleptic pimozide (Orap).
Topics: Aged; Facial Muscles; Female; Humans; Male; Middle Aged; Movement Disorders; Pimozide | 1982 |
No neurological improvement after liver transplantation for Wilson's disease.
Topics: Adult; Antipsychotic Agents; Cerebellum; Cognition Disorders; Demyelinating Diseases; Follow-Up Studies; Hepatolenticular Degeneration; Humans; Intelligence Tests; Liver Transplantation; Male; Movement Disorders; Pimozide; Pons | 1995 |
Clozapine for the control of hemiballismus.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Clozapine; Haloperidol; Humans; Hypnotics and Sedatives; Male; Movement Disorders; Phenobarbital; Pimozide | 1994 |
On the mechanism(s) of cholecystokinin (CCK): receptor stimulation attenuates morphine dependence in mice.
Topics: Adrenergic Antagonists; Animals; Atropine; Benzazepines; Ceruletide; Dopamine Antagonists; Male; Methysergide; Mice; Morphine; Morphine Dependence; Movement Disorders; Muscarinic Antagonists; Naloxone; Narcotic Antagonists; Phenoxybenzamine; Pimozide; Propranolol; Receptors, Cholecystokinin; Serotonin Antagonists; Sincalide; Substance Withdrawal Syndrome; Sulpiride | 1997 |
The treatment of the choreas and athetotic dystonias.
Topics: Adult; Athetosis; Benzodiazepines; Child; Chorea; Dystonia; Haloperidol; Humans; Levodopa; Movement Disorders; Phenelzine; Phenothiazines; Pimozide; Tetrabenazine; Valproic Acid | 1979 |
Acute dystonia as an idiosyncratic response to neuroleptics in baboons.
Topics: 5-Hydroxytryptophan; Acute Disease; Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Haloperidol; Haplorhini; Humans; Levodopa; Movement Disorders; Papio; Parasympatholytics; Physostigmine; Pimozide; Receptors, Dopamine; Reserpine; Syndrome; Tranquilizing Agents | 1977 |
Restless legs syndrome and periodic leg movements in sleep: the primary role of dopaminergic mechanism.
Topics: Codeine; Dopamine; Humans; Male; Middle Aged; Movement Disorders; Pimozide; Restless Legs Syndrome; Restraint, Physical; Sleep Wake Disorders; Syndrome | 1991 |
Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette's disorder.
Topics: Acute Disease; Adolescent; Aggression; Akathisia, Drug-Induced; Antipsychotic Agents; Child; Child, Preschool; Dyskinesia, Drug-Induced; Haloperidol; Hostility; Humans; Male; Movement Disorders; Pimozide; Tourette Syndrome | 1988 |
Persistent hemiballismus with lesions outside the subthalamic nucleus.
Topics: Aged; Basal Ganglia Diseases; Corpus Striatum; Humans; Male; Middle Aged; Movement Disorders; Pimozide; Tomography, X-Ray Computed; Valproic Acid | 1985 |
Reversal of reserpine-induced bradykinesia by alpha-methyldopa--new light on its modus operandi.
Topics: Animals; Carbidopa; Chlorpromazine; Dihydroxyphenylalanine; Disease Models, Animal; Disulfiram; Dose-Response Relationship, Drug; Drug Synergism; Methyldopa; Mice; Movement Disorders; Parkinson Disease; Phenoxybenzamine; Pimozide; Reserpine | 1974 |
Role of noradrenaline in levodopa reversal of reserpine akinesia.
Topics: Animals; Chlorpromazine; Dihydroxyphenylalanine; Haloperidol; Mice; Movement Disorders; Norepinephrine; Phenoxybenzamine; Pimozide; Reserpine | 1974 |